Robert Kralovics

Center for Molecular Medicine, Austrian Academy of Sciences, Austria
Professor

Scopus Profile: link
Researcher ID: DVE-7862-2022
Profile Google Scholar: link
ID ORCID: http://orcid.org/0000-0002-6997-8539

Professional (scientific) interests: Hematopoietic malignancies (genetics and therapy); Cancer genetics

Selected Publications:

  1. Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva-Kyuchukova, L., Egyed, M., Dulicek, P., Illes, A., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Krejcy, K., Empson, V., Hasselbalch, H. C., Kralovics, R., Kiladjian, J.-J., Gisslinger, H., Kiladjian, J.-J. (2023). Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment. Leukemia, 37 (10), 2129–2132. doi: https://doi.org/10.1038/s41375-023-02008-6

  2. Kralovics, R., Ivanov, D., Milosevic Feenstra, J. D., Sadovnik, I., Herrmann, H., Peter, B., Willmann, M., Greiner, G., Slavnitsch, K., Hadzijusufovic, E., Rülicke, T., Dahlhoff, M., Hoermann, G., Machherndl‐Spandl, S., Eisenwort, G., Fillitz, M., Sliwa, T., Krauth, M., Bettelheim, P., Sperr, W. RValent, P. et al. (2023). Phenotypic characterization of disease‐initiating stem cells in JAK2 or CALR‐mutated myeloproliferative neoplasms. American Journal of Hematology, 98 (5), 770–783. doi: https://doi.org/10.1002/ajh.26889

  3. Luque Paz, D., Kralovics, R., Skoda, R. C. (2022). Genetic basis and molecular profiling in myeloproliferative neoplasms. Blood, 141 (16), 1909–1921. doi: https://doi.org/10.1182/blood.2022017578

  4. Pecquet, C., Papadopoulos, N., Balligand, T., Chachoua, I., Tisserand, A., Vertenoeil, G., Nédélec, A., Vertommen, D., Roy, A., Marty, C., Nivarthi, H., Defour, J.-P., El-Khoury, M., Hug, E., Majoros, A., Xu, E., Zagrijtschuk, O., Fertig, T. E., Marta, D. S., Constantinescu, S. N. et al. (2023). Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms. Blood, 141 (8), 917–929. doi: https://doi.org/10.1182/blood.2022016846

  5. Lin, W.-Y., Fordham, S. E., Hungate, E., Kralovics, R., Onel, K., Allan, J. M. (2022). Genome-wide association study identifies susceptibility loci for acute myeloid leukemia. Nature Communications, 13 (1), 2. doi: https://doi.org/10.1038/s41467-021-26551-x 

  6. Kiladjian, J.-J., Klade, C., Georgiev, P., Kralovics, R., Yablokova, V., Gisslinger, H. (2022). Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b. Leukemia, 36 (5), 1408–1411. doi: https://doi.org/10.1038/s41375-022-01528-x 

  7. Milosevic Feenstra, J.D., Jäger, R., Schischlik, F., Kralovics, R., Valent, P. (2022). PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms. American Journal of Hematology, 97 (4), 390–400. doi: https://doi.org/10.1002/ajh.26461